ArticleFrontiers in molecular biosciences2023

Harnessing IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in α-synucleinopathies.

Sofia Zaichick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.